Watson Pharmaceuticals, Inc. Files Oxytrol Patent Suit Against Barr Pharmaceuticals, Inc.
CORONA, Calif. - Watson Pharmaceuticals Inc. is suing Barr Pharmaceuticals Inc. to prevent Barr from selling a generic version of the Oxytrol overactive bladder patch, Watson said Friday.